Pacira BioSciences, Inc. Recorded Big Gain
Thu, Oct 08, 2026 at 07:39 PM
Pacira BioSciences, Inc. (PCRX:NASDAQ) jumped higher at $36.39, representing a gain of 44.4%. On Thu, Oct 08, 2026, PCRX:NASDAQ touched a New 2-Week High of $36.39. The stock got featured on our News Catalysts scanner on Thu, Oct 08, 2026 at 03:19 PM in the 'ACQUISITION' category. From Thu, Sep 24, 2026, the stock recorded 50.00% Up Days and 54.55% Green Days
About Pacira BioSciences, Inc. (PCRX:NASDAQ)
Pacira Pharmaceuticals Inc is a specialty and generic drug manufacturing company. The company develops, manufactures, and commercializes pharmaceutical products for use in hospitals and ambulatory surgery centers across the United States.
Top 10 Gainers:
- Fly-E Group, Inc. (FLYE:NASDAQ), 82.68%
- Jianzhi Education Technology Group Company Limited (JZ:NASDAQ), 77.44%
- Xiao-I Corporation (AIXI:NASDAQ), 46.21%
- Pacira BioSciences, Inc. (PCRX:NASDAQ), 44.4%
- Quanome Technologies Inc Com (QNME:NASDAQ), 43.28%
- The OLB Group, Inc. (OLB:NASDAQ), 41.86%
- WISeSat.Space Holdings Corp. (SAIQ:NASDAQ), 41.65%
- Grande Group Limited (GRAN:NASDAQ), 23.12%
- RedHill Biopharma Ltd. (RDHL:NASDAQ), 21.94%
- Profound Medical Corp. (PROF:NASDAQ), 21.65%